- Home
- ACHV vs SEVN Comparison
ACHV vs SEVN Comparison
Compare ACHV & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHV | SEVN |
|---|---|---|
| Founded | N/A | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.0M | 187.6M |
| IPO Year | 2018 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ACHV | SEVN |
|---|---|---|
| Price | $4.56 | $8.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $14.67 | $10.50 |
| AVG Volume (30 Days) | ★ 1.6M | 117.4K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 13.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $29,383,000.00 |
| Revenue This Year | N/A | $27.75 |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | ★ N/A | $43.47 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.00 | $7.90 |
| 52 Week High | $6.03 | $12.85 |
Technical Indicators
Market Signals| Indicator | ACHV | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 60.45 | 55.37 |
| Support Level | $4.04 | $8.33 |
| Resistance Level | $5.13 | $8.95 |
| Average True Range (ATR) | 0.42 | 0.20 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 44.16 | 69.39 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.